Gene therapy with the gene for interleukin-2 delivered by a retroviral vector data

The San Diego company reported results of an ongoing Phase I trial in China at the International Conference of Gene Therapy for Cancer in San Diego, saying the treatment was safe, with almost no side effects, and was associated with reduction in tumor mass and in pleural effusion in six of the 10 patients evaluated so far. ...